6-(2,2,2-TRIFLUOROETHYL)THIENO[2,3-D]PYRIMIDIN-4(3H)-ONE, 95.0%, 50mg

4,5-Dimethylthiazole-2-carbaldehyde, 95.0%, 25g

2-Amino-2-(thiophen-2-yl)ethanol hydrochloride, 97.0%, 250mg

4-Fluoro-2-methyl-3-nitrobenzoic acid, 97.0%, 100mg

6-ACETYL-2(3H)-BENZOXAZOLONE, 95.0%, 5g

8-(Benzyloxy)-1,4-dioxaspiro[4.5]decane, 95.0%, 500mg

[1,1'-Biphenyl]-4'-bromo-4-carboxylic acid, 98.0%, 5g

(5E)-2-mercapto-5-(mesitylmethylene)-1,3-thiazol-4(5H)-one, 95.0%, 1g

1,1'-(Butane-1,4-diyl)bis(3-(3-isothiocyanatophenyl)thiourea), 98%, 10mg

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

(1R)-1-(2,4-Dimethoxyphenyl)ethan-1-amine, 95+%, 250mg

O-(4-Nitrobenzoyl)hydroxylamine, 95.0%, 10g

Potassium hexachloroplatinate(IV), min. 99.9%, pa, 1 g, glass packaging